In vitro angiogenesis and expression of nuclear factor κB and VEGF in high and low metastasis cell lines of salivary gland Adenoid Cystic Carcinoma by Zhang, Jiali & Peng, Bin
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Cancer
Open Access Research article
In vitro angiogenesis and expression of nuclear factor κB and VEGF 
in high and low metastasis cell lines of salivary gland Adenoid Cystic 
Carcinoma
Jiali Zhang and Bin Peng*
Address: Key Lab for Oral Biomedical Engineering of Ministry of Education, School and Hospital of Stomatology, Wuhan University, China
Email: Jiali Zhang - ringsing@yahoo.com.cn; Bin Peng* - phs@vip.163.com
* Corresponding author    
Abstract
Background: Adenoid cystic carcinoma is a high malignant carcinoma characterized by intensive
local invasion and high incidence of distant metastasis. Although many reports have demonstrated
that angiogenesis has played an important role in tumor metastasis, the relationship between
metastasis characters and angiogenesis ability in high and low metastasis cell lines of Adenoid cystic
carcinoma has rarely been reported. The present study aimed to compare the angiogenesis ability
of ACC-M (high metastasis) and ACC-2 (low metastasis) cell lines in vitro. Furthermore, the
activity of nuclear factor κappa B and the expression of vascular endothelial growth factor (VEGF)
in ACC-2 and ACC-M were also detected.
Methods: Electrophoretic mobility shift assay was used to detect nuclear factor κappa B activity.
Semi-quantitative RT-PCR was used to quantify the mRNA level of VEGF. Immuofluorescence
double staining and semi-quantitative confocal laser scanning analysis was carried out to detect
nuclear factor κappa B nuclear localization and staining intensity of VEGF. The angiogenesis ability
of ACC-M and ACC-2 was compared by an in vitro three-dimensional angiogenic model assay. The
vector transfection assay was performed to transfect the PCMV-IκBαM vector into ACCs cell lines
expressing the phosphorylation defective IκBαM.
Results: Nuclear factor κappa B activity and the rate of nuclear factor κappa B nuclear localization
in ACC-M was significantly higher than that in ACC-2. Moreover, ACC-M exhibited higher mRNA
and protein levels of vascular endothelial growth factor than ACC-2. VEGF mRNA expression was
effectively decreased by inhibition of nuclear factor κappa B activity. Furthermore, ACC-M could
remarkably stimulate the migration and tube formation of endothelial cells and induce The umbilical
vein endothelial cells sprouting into the gel matrix.
Conclusion:  These results implicated that ACCs cells with higher metastasis feature might
present greater angiogenesis ability.
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Introduction
Adenoid cystic carcinoma of salivary glands (ACCs) is a
high malignant carcinoma characterized by intensive
local invasion and insidious distant metastasis to the lung
at an early stage, which is responsible for a poor long-term
survival rate [1]. Although reasons of the invasiveness and
aggressive metastatic dissemination of ACCs remain
unclear, angiogenesis might be a possible involving mech-
anism [2]. Our previous study showed that the ACCs his-
tological type which presented high metastasis tendency
exhibited higher microvessel density levels and more
intensive expression of angiogenic related factors [3].
Angiogenesis, the development of new blood vessels from
the pre-existing vascular beds, is an essential pathophysi-
ologic event occurring in tumor growth and metastasis.
There are various factors involved in angiogenesis, includ-
ing the vascular endothelial growth factor (VEGF), which
plays a key role in regulating tumor vascularization [4]. In
addition, VEGF has demonstrated a major association
with initiating the process of angiogenesis through regu-
lating proliferation, migration, and differentiation of
endothelial cells [5]. On the other hand, the nuclear tran-
scription factor κB (NF-κB) that was reported increased in
cancers and promoted tumor angiogenesis [6]. Once acti-
vated, NF-κB p50 and p65 will translocate into nuclear
and up-regulates a number of genes necessary for the ang-
iogenesis of tumors, which have κB binding sites in their
promoter regions [7]. Further, recent evidence has indi-
cated that an over-expression of NF-κB is the key compo-
nents of the angiogenic cascade, which contribute to
VEGF-induced angiogenesis through up-regulation of
VEGF mRNA expression in many tumors [5,8]. Our previ-
ous study has demonstrated the expressed relationship
between VEGF and NF-κB: the staining intensity of VEGF
was significantly correlated with NF-κB nuclear localiza-
tion rate in 80 ACCs clinical samples [3].
To our knowledge, however, there were few reports about
the relationship between the distant metastasis character
and the angiogenesis ability in ACCs, mainly because it is
uncommon, and more than a decade of observation
might be required to appreciate the prolonged clinical
course in some patients. As a result, using an in vitro
model to study the angiogenesis ability in high and low
metastasis ACCs cell lines is necessary. The low metastasis
cell line ACC-2 was established from ACCs in 1988 [9],
and the high metastasis cell line ACC-M was a highly
metastastic clone to the lung selected from ACC-2 [10].
The metastatic rate was 96% vs. 18% for ACC-M and ACC-
2 cell line. Since the high and low metastasis cell lines
were established, reports have been made to explore the
difference between the two cell lines on the cell and
molecular level associated with tumor metastasis [11].
In our present research, the relationship between angio-
genesis and metastasis in ACC-M and ACC-2 cell lines has
been studied. We use the in vitro angiogenesis model to
compare the angiogenesis abilities in high and low metas-
tasis cell lines of human ACCs. Furthermore, the NF-
κBp65 activity and VEGF expression levels in the two cell
lines were also detected.
Methods
Cell culture
The high and low metastasis cell lines of human ACCs
(ACC-2 and ACC-M) [12] were obtained from the China
Center for Type Culture Collection. The umbilical vein
endothelial cell line (UVEC) was from the Key Lab for
Oral Biomedical Engineering of Ministry of Education at
Wuhan University. Cells were maintained at 37°C in
DMEM and supplemented with 10% fetal bovine serum
(GIBCO, Trace Biosciences Ltd., Sydney, Australia) under
5% CO2/95% air atmosphere and passed at a 4–7 split
before use in the following experiments.
To obtain the conditioned medium (CM), sub-confluent
ACC-M and ACC-2 cells were serum starved for 12 h in 6
well plates (Greiner, Labotechnik, Germany). The
medium was replaced with 1.0 ml serum-free DMEM
medium, and the cells were then incubated for 12 h, after
which the CM were obtained, stored at -20°C, and used
for the following experiments. The viability of cells was
estimated by CCK-8 kit (Japan, Kumamoto, Dojindo).
Electrophoretic Mobility Shift Assay
EMSA were performed using nuclear extracts as follows:
10 ug of nuclear extract in a 10-ul reaction volume was
incubated on ice for 40 min. Double-stranded Oligonu-
cleotide DNA probes, (κB: 5'-AGTTGAGGGGACTTTC-
CCAGGC-3', and Oct-1:5'-TGTCGAATGCAAAT
CACTAGAA-3') were end-labeled with 32P-γ, and applied
to a 4% nondenatured polyacrylamide gel. Equal loading
of nuclear extracts was confirmed by determining Oct-1
DNA binding activity. After electrophoresis, the gel was
dried for 1 h at 80°C and exposed to Kodak X-ray film
(Eastman Kodak Co., Rochester, NY, USA) at -80°C.
Semi- quantitative Reverse Transcription-PCR
Total RNA was extracted from 1 × 106 of ACC-M and ACC-
2 cells using TRIzol (Invitrogen, crop. Carlsbad, CA, USA).
Aliquots (1 ug) of RNA were reverse transcribed to cDNA
and aliquots (4 ul) of cDNA were used as a template for
PCR using a PE9700 RT-PCR system (Applied Biosystems,
Singapore) according to the manufacturer's instructions.
The primers sets were as follows: VEGF (682 bp), 5'ggc tct
aga tcg ggc ctc cga aac cat3' and 5'ggc tct aga gcg cag agt ctc
ctc ttc3'; β-actin(434 bp), 5'tgt gcc cat cta cga ggg gta tgc3'
and 5'ggt aca tgg tgg tgc cgc cag aca3'. Thermocycling con-
ditions were melting at 95°C for 30 s; anneal at 63.5°CBMC Cancer 2007, 7:95 http://www.biomedcentral.com/1471-2407/7/95
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(VEGF 27 cycles) for 45s, or 57°C(β-actin 25 cycles) for
30s; extension at 72°C for 30s. The PCR products were
analyzed by electrophoresis in a 2% agarose gel. The rela-
tive RNA amount was calculated by the Gene Genius gel
imaging system (Syngene, UK). All experiments were car-
ried out three times: each time the reading was taken in
triplicate and the average and standard deviations were
calculated.
Immuofluorescence double staining and semi-quantitative 
confocal laser scanning analysis
Cells were fixed with methanol for 10 minutes at -20°C.
After permeated with 0.5% Triton X-100 in PBS for 10
minutes at room temperature, cells were blocked by 2%
bovine serum albumin for 30 minutes at 37°C. Then cells
were incubated with the primary antibodies overnight at
4°C. Primary antibodies were anti-NF-κB mouse mono-
clonal antibody (Santa Cruz, CA, USA) used at a dilution
of 1:100, and anti-VEGF rabbit polyclonal antibody
(Santa CruZ, CA, USA) used at a dilution of 1:150. After
washing with TBST, the cells were incubated with second-
ary antibodies, diluted 1:80 in TBST. Secondary antibod-
ies that were used were CY3-conjugated goat anti-rabbit
IgG (Sigma, St. Louis, USA) and fluorescein isothiocy-
anate (FITC)-conjugated goat anti-mouse IgG (Pierce,
Rockford, USA). The cells were then washed three times
with PBS. Immunofluorescence microscopy was per-
formed using a Leica TCS-SP2-AOBS-MP confocal micro-
scope (Leica Microsystem, Heidelberg, Germany).
According to the recommendation of Nakayama [13], the
rate of the nuclear localization of p65 was calculated by
the following method: count positive nuclear staining NF-
κB from total cells and then calculate the percentage. Each
of the five cell slides was counted every ten randomly
selected in high-power fields (× 200). The relative protein
amount of VEGF was calculated according to the mean
intensity of the fluorescence on five cell slides by Leica
confocal software 2.61.
Stable Transfection of ACCs Cells with IκBαM and Control 
vector
The PCMV-IκBαM vector was provided by Professor
Chiao (Anderson Cancer center, Huston, Texa, USA). The
CMV-IκBαM vector has mutations (S32, 36A) of the NH2
terminus and a COOH-terminal PEST sequence, which
specifically inhibits phosphorylation of IκBα. Then ACC-
M and ACC-2 cells (1 × 106) were transfected using 15 ul
of lipofectamine reagent (Invitrogen, Grand Island, NY,
USA) and 4 ug of PCMV-IκBαM or control PCMV vector
according to the manufactures instruction. Cells were
selected with standard medium containing 800 ug/ml and
600 ug/mlG418 respectively. Fourteen days later, neo-
resistant colonies were isolated by trypsinization and
established as subcultures. The cells resistant G418 and
stable express exogenous IκBαM were used for subsequent
analyses.
Endothelial cell migration assay
Endothelial cell motility assay was carried out as
described previously [14]. Briefly, a 6-well plate was
coated with type-I collagen and incubated overnight at
37°C. UVECs were seeded into the coated wells at a den-
sity of 2 × 106 cells/well and incubated for 24 h. Then
scrape the monolayer cells to make a clear area with a nar-
row tip and wash with serum-free medium. 1.0 ml CM
from ACC-M and ACC-2 cells were added into the wells
and incubated for 24 h, and the 1.0 ml serum free DMEM
medium was used as the control. Then the cells were fixed
and stained using Acridine Orange and photographed by
fluorescence microscope (Leica Microsystem, Heidelberg,
Germany).
Tube formation assay
500 ul type I collagen gel solution (0.3%) containing 5
mg/ml of human fibronectin (Collaborative Research Inc.
Lexingtonf, USA), 100 ul 10 × DMEM and 400 ul NaOH-
Heppers buffer was mixed in an ice cold condition and
pipetted into a 6-well plate and kept for 30 min at 37°C
or gelatinization. UVECs were seeded into the layer of the
gel at a density of 5 × 104  cells/well with 10% FBS
medium. After 24 h, the medium was replaced by 0.8 ml
CM from ACC-M and ACC-2 cells, which was added with
0.2 ml 10% FBS DMEM medium to reach the 2% FBS-CM
final concentration. The 1.0 ml 2% FBS medium was used
as the control [15]. After 3 days, the tubular structures
organized and gradually elongated and formed networks
by UVEC cells. Then the cells were fixed and stained using
Acridine Orange and photographed by a fluorescence
microscope (Leica Microsystem, Heidelberg, Germany).
In vitro three-dimensional angiogenic assay model
In vitro three-dimensional angiogenic assay model was
then performed as described previously [2]. Briefly, the
type I collagen gel solution mixture was put on a filter of
Millicell-CM inserts and placed in 6-well plates. After
gelatinization of the collagen solution, UVEC cells (1 ×
105 cells) were seeded on the surface of the gels in the Mil-
licell and cultured in 10% FBS. When the UVEC cells
reached subconfluence about 24 h after seeding, the
medium in the outer wells was replaced by 1.5 ml 2.0%
FBS-CM and the 1.5 ml 2.0% FBS medium was used as the
control. In the Millicell well, 0.5 ml of 2.0% FBS medium
was added. Within a week of culture, UVEC cells started to
sprout into the gels beneath the confluent monolayer.
Then the gels were fixed and stained using Acridine
Orange, and the sprouting structures were observed using
a Leica LSM 410 confocal laser scanning microscope.BMC Cancer 2007, 7:95 http://www.biomedcentral.com/1471-2407/7/95
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Statistical evaluation
The experiments were repeated thrice and all data are pre-
sented as mean ± S.D. Statistical analysis was performed
by ANOVA test. The Spearman rank correlation coefficient
test was applied for the correlation among the expression
of NF-κB and VEGF. P-values less than 0.05 were consid-
ered to be significant.
Results
NF-κBp65 activity and mRNA expression level of VEGF in 
ACCs cell lines
NF-κBp65 DNA binding activity in the nuclear extracts
from ACC-M and ACC-2 cell lines was showed in Figure 1,
lane 1–2. There was a constitutive NF-κBp65 activity in
ACC-M and ACC-2 cell lines. In the ACC-M, the intensity
of the shift band of p65/P50 was much stronger than that
in ACC-2.
Figure 2 showed the mRNA expression band of VEGF in
ACC-2 and ACC-M. The mean level of VEGF mRNA in
ACC-M (0.575 ± 0.10) was about 2-fold than that in ACC-
2 (0.309 ± 0.11), and the statistical difference was deemed
significant (P < 0.01) [see additional file 1].
Nuclear localization of NF-κB and semi-quantity 
immunofluorescence of VEGF in ACCs cell lines
As Figure 3A showed, the green fluorescence is the NF-κB
p65 staining, which was detected in almost all of the cyto-
Immuofluorescence double staining and semi-quantitative  confocal laser scanning analysis showed NF-κB p65 and  VEGF expressed in ACC-M and ACC-2 cell lines Figure 3
Immuofluorescence double staining and semi-quantitative 
confocal laser scanning analysis showed NF-κB p65 and 
VEGF expressed in ACC-M and ACC-2 cell lines. As figure 
3A showed, the rate of NF-κB p65 nuclear localization (a) 
(white arrow) and VEGF staining intensity (b) in ACC-M was 
higher than that in ACC-2 (e) and (f). As figure 3B shows, 
bars represent the mean value of immunofluorescence inten-
sity of VEGF and nuclear staining rate of NF-κB p65 in two 
cell lines, P < 0.01(*).
EMSA showed the activity of NF-κB p65 in ACC-M, ACC-M/ IκBαM, ACC-2 and ACC-2/IκBαM cell lines Figure 1
EMSA showed the activity of NF-κB p65 in ACC-M, ACC-M/
IκBαM, ACC-2 and ACC-2/IκBαM cell lines. Arrows indicate 
the migration of the induced NF-κB DNA-binding com-
plexes. Migration of the free probe is not shown. The Oct-1 
motif was used as a control for quality and quantity of cell 
extract.
RT-PCR showed the mRNA expression of VEGF in ACC-M,  ACC-2, ACC-M/IκBαM and ACC-2/IκBαM cell lines Figure 2
RT-PCR showed the mRNA expression of VEGF in ACC-M, 
ACC-2, ACC-M/IκBαM and ACC-2/IκBαM cell lines.BMC Cancer 2007, 7:95 http://www.biomedcentral.com/1471-2407/7/95
Page 5 of 7
(page number not for citation purposes)
plasm but only some of the nucleus in ACCs cells. The
mean rate of NF-κB p65 nuclear staining detected in ACC-
M and ACC-2 was 30.35 ± 2.52% and 17.97 ± 1.50%,
respectively. The rate of NF-κB p65 nuclear localization in
ACC-M was significantly higher than that in ACC-2 (P <
0.01).
The red fluorescence detected in the cytoplasms of ACCs
cells is the VEGF staining. The mean immunofluorescence
intensities of VEGF in ACC-M and ACC-2 cell lines were
38.98 ± 4.98 and 24.10 ± 1.57, respectively (Figure 3). The
expression level of VEGF in ACC-M was significantly
higher than that in ACC2 (P < 0.01, Figure 3B).
The Spearman Correlation analysis was performed to
quantitate the association between two variables. The
expression level of VEGF was significantly correlated to
NF-kB p65 nuclear localization in both of the ACC-M and
ACC-2 cell lines (P < 0.01).
Down regulation of VEGF mRNA expression by inhibition 
of NF-κBp65 activation
ACC-M and ACC-2 cells were transfected with the mutant
IκBα expression vector. The constitutive NF-κBp65 activ-
ity found in ACC-M and ACC-2 cell lines was completely
abolished in ACC-M/IκBαM and ACC-2/IκBαM cell lines
(figure 1, lane 3–4). Furthermore, the constitutive mRNA
expression level of VEGF was effectively inhibited by over-
expression of IκBαM in ACC-M/IκBαM and ACC-2/
IκBαM cells (figure 2, lane 3–4).
ACCs cell lines enhanced the migration of endothelial cells
After 24 hours of culture, the scrape-wounded UVECs
monolayers incubated with medium from ACC-M
showed that cells migrated into the denuded area more
densely than the ones incubated with medium from ACC-
2 (Figure 4b, c). On the other hand, in the medium from
control cultures, the cells sparsely migrated into the
denuded area and the wound remained open (Figure 4a).
ACCs cell lines stimulated the tube formation of 
endothelial cells
In the presence of medium from ACC-M, UVECs formed
organized elongated tube-like structures resembling capil-
laries with an extensive network (Figure 4f). While in the
presence of medium from ACC-2, the formation of the
tubular-like structures and networks by UVECs were
decreased (Figure 4e). However, cultured with medium
from the control, tube formation was diminished and no
such well-organized structures were observed (Figure 4d).
The results indicated that ACCs cells with high metastasis
ability could stimulate the tube formation of angiogen-
esis.
ACCs cell lines stimulated the UVEC sprouting into the gels 
matrix
After a week of culture with medium from ACC-M in the
outer well, the tubules structure grew further thickening
into the gel and the monolayer on surface of the gel grad-
ually reach sub-confluence. At the thickened branch
points of the tubules structure, the UVECs sprouting into
the gel matrix could be observed by the confocal laser
scanning microscope (Figure 5c). The mean thickness of
sprouting was 53.96 um (Figure 5f). While cultured with
the medium from ACC-2, there were less UVECs sprout-
ing into the gel matrix (Figure 5b) and the mean thickness
of sprouting was 21.76 um (Figure 5e). It showed that
UVECs cultured with ACC-M (figure 5f) presented more
cell sprouting points and thicker sprouting layers than cul-
tured with ACC-2 (figure 5e). On the other hand, UVECs
cultured with medium from the control only formed
In vitro three-dimensional angiogenic assay of endothelial  cells Figure 5
In vitro three-dimensional angiogenic assay of endothelial 
cells. Control (figure 5a), ACC-2 (figure 5b) and ACC-M (fig-
ure 5c) induce UVECs sprouting into the gel matrix (white 
arrow) and the mean thickness of sprouting was showed by 
figure 5d, figure 5e and figure 5f. UVECs cultured with ACC-
M (figure 5f) shows more cell sprouting points and thicker 
sprouting layers than cultured with ACC-2 (figure 5e).
Migration and tube formation of endothelial cells Figure 4
Migration and tube formation of endothelial cells. UVECs 
were cultured with the conditioned medium from control 
(a), ACC-2(b) and ACC-M (c) for migration assay. Edges of 
the denuded areas are marked by dashed lines. UVECs were 
cultured with the conditioned medium from control (d), 
ACC-2(e) and ACC-M (f) for tube formation assay. One of 
tube-like structure was marked by asterisk (*) in figure b and 
c.BMC Cancer 2007, 7:95 http://www.biomedcentral.com/1471-2407/7/95
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uncompleted tubule structures on the surface of gel, and
almost no sprouting cells could be observed.
Discussion
The great potential for hematogenous metastasis at an
early stage is one of the unique characters of ACCs. Our
previous study showed that the high expressions of angio-
genesis related factors NF-κB and VEGF were significantly
correlated to lung metastasis and solid histotype, which
present high metastasis tendency [3]. In the current study,
we used high and low metastasis cell lines of human
ACCs-ACC-M and ACC-2- to compare the angiogenic
related factor NF-κB and VEGF expression levels. We also
compared the ability of angiogenesis between the two cell
lines by in vitro cell migration, tube formation and
sprouting assay.
The tumor cells induced secretion of angiogenesis factors
which is commonly observed in most aggressive tumors
[16]. Among various angiogenic factors, the most notable
is VEGF, which exerts its mitogenic activity especially on
endothelial cells [5]. Our findings revealed that NF-κBp65
activity detected in the high metastasis cell line ACC-M
was much greater than that in the low metastasis cell line
ACC-2, and the VEGF mRNA expression level in the high
metastasis cell line ACC-M was almost 2-fold than that in
the low metastasis cell line ACC-2. Moreover, the protein
staining intensity of VEGF in ACC-M is also significantly
higher than that in ACC-2. The results are consistent with
the evidence that the tumor-induced VEGF expression and
NF-κB activity correlated with tumor metastasis [8,17]. It
was suggested that the aberrant activity of NF-κB and
VEGF level might be the possible mechanisms involved in
the high metastasis ability of ACC-M cell lines.
In the neovascularization of several neoplasms, research
have shown the potent angiogenic factor VEGF, whose
genes have a κB binding site, are regulated by activated
NF-κB [18,19]. Once triggered and activated, freed NF-κB,
in the heterodimer of the p65 and p50 subunits, translo-
cates from the cytoplasm into the nucleus and binds to the
specific sequence in the promoter of target genes. In our
study, it was found that the constitutive activity of NF-
κBp65 detected in ACC-M and ACC-2 cells. In these cell
lines, inhibition of NF-κBp65 activity by a PCMV vector
mediated expression of phosphorylation defective mutant
of IκBα effectively inhibited the expression of VEGF
mRNA. Furthermore, the nuclear staining rate of NF-
κBp65 was significantly correlated with VEGF protein
level in both ACC-M and ACC-2 cell lines. These results
suggest that NF-κBp65 is involved in the regulation of
VEGF expression. This hypothesis is supported by the
findings of others. The study of Tamami et al. [20] dem-
onstrated the inhibitors of the transcription factors NF-κB
completely prevented the advanced glycation end prod-
ucts (AGE)-induced up-regulation of VEGF mRNAs and
the subsequent increase in DNA synthesis in endothelial
cells. The authors suggested that NF-κB activation might
be involved in the AGE-elicited angiogenesis through
overproduction of auto-secretion VEGF proteins. Huang
et al. demonstrated a concordant increase in NF-κB activ-
ity with the elevated VEGF mRNA in ovarian cancer cells
[21]. In this cell line, stable expression of mutated IκBα
resistant to degradation, decreased NF-κB activity and
reduced VEGF mRNA expression, suggesting that the reg-
ulation of VEGF by NF-κB is mediated at the transcription
level.
The angiogenic process includes endothelial cell activa-
tion, proliferation, migration, tube formation, and capil-
lary sprouting [22]. It increases the opportunity to
improve the development of metastases [23] in many
malignant tumors, such as gastro-intestinal tumors [24],
colorectal cancer [25], lung adenocarcinoma [26], and
hepatocellular carcinoma [27]. VEGF and NF-κB have
been reported to be crucial in new blood vessel formation
[14]. Those angiogenic-related factors increase the oppor-
tunity for malignant cells distance metastases through the
leakage basement vessel, and hence profoundly influence
the prognosis of cancer patients [5,17]. To further indicate
the angiogenesis abilities in different metastasis cells lines
of ACCs, the in vitro angiogenesis model was also
employed. Through in vitro three-dimensional ang-
iogenic assay model, our present study showed ACC-M,
the highly metastasis cell clone, could remarkably
enhanced the migration and tube formation of UVECs
and induce UVECs sprouting into the gel matrix. ACC-M
cells presented higher angiogenic activity might result
from its higher VEGF expression levels and NF-κB activity
which were crucial in tumor angiogenesis [8,20,21]. The
findings of Ishibashi's experiment also showed that spe-
cific VEGF antibody could inhibit the in vitro angiogenic
activity in human salivary gland carcinoma cells [2]. As a
result, it might raise the possibility that the high metasta-
sis cell line ACC-M present higher angiogenic-related fac-
tors might facilitate the further angiogenesis.
In conclusion, our current study has shown human ACCs
cells with high metastasis potential express high levels of
constitutive NF-κB p65 activity and VEGF expression. Sup-
pression of NF-κB p65 activity through stable expression
of a phosphorylation defective IκBα mutant (S32, 36A)
significantly decreased VEGF expression. Furthermore,
ACC-M could remarkably stimulate the migration and
tube formation of endothelial cells and induce UVECs
sprouting into the gel matrix. The results indicate that in
ACCs, cells with higher metastasis potential might present
greater angiogenesis ability. Our further study will investi-
gate the function of NF-κB p65 signaling in angiogenesis
and metastasis of ACCs cells.BMC Cancer 2007, 7:95 http://www.biomedcentral.com/1471-2407/7/95
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